Advertisement

Digestive Diseases and Sciences

, Volume 38, Issue 8, pp 1530–1536 | Cite as

Alterations in rat intestinal transit by morphine promote bacterial translocation

  • Norbert S. F. Runkel
  • Frank G. Moody
  • Gregory S. Smith
  • Liliana F. Rodriguez
  • Ying Chen
  • Mark T. Larocco
  • Thomas A. Miller
Original Articles

Abstract

Translocation of enteric microorganisms from the intestinal tract to extraintestinal sites has been proposed as an early step in the development of gram-negative sepsis. This study examined the role of altered bowel transit in influencing intestinal bacteriostasis and bacterial translocation using morphine as a pharmacologic inhibitor of such transit. In the first experiment, either normal saline (N=8) or morphine sulfate (20 mg/kg;N=8) was injected subcutaneously. Two hours later, morphine (7.5 mg/kg) was infused subcutaneously for an additional 22 hr; control animals received saline alone. After completion of this regimen, a volume of 0.2 ml of 2.5 mM FITC dextrans (10,000 daltons) were injected intraduodenally in each group. The bowel was removed 25 min later, divided into 5-cm segments, and the content of dextrans measured. Small bowel propulsion was expressed as the geometric center of the distribution of dextrans throughout the intestine (in percentage length of small bowel). Gut propulsion was significantly reduced after morphine treatment as compared to controls (32.8±8.2% vs 55.8±4.0%;P<0.01). In 16 additional rats, saline or morphine was again administered as described. After 24 hr, samples were obtained from the mesenteric lymph node (MLN) complex, blood, spleen, liver, duodenum, jejunum, ileum, and cecum for standard bacteriology. The bacterial counts increased significantly in each intestinal segment following morphine treatment. Microorganisms translocated to the MLN complex in 5, and to distant sites in four of eight morphine-treated animals, respectively. Translocation to the MLN complex occurred in only one of eight controls (P<0.05); no translocation to distant sites occurred in control animals. We conclude that the morphine-induced prolongation in bowel transit promotes bacterial translocation secondary to an overgrowth of enteric bacteria in the intestinal lumen.

Key Words

translocation sepsis morphine microorganism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berg RD, Garlington AW: Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23:403–411, 1979Google Scholar
  2. 2.
    Deitch EA, Maejima K, Berg R: Effect of oral antibiotics and bacterial overgrowth on the translocation of GI tract microflora in burned rats. J Trauma 25:385–392, 1985Google Scholar
  3. 3.
    Wells CL, Rotstein OD, Pruett TL, Simmons RL: Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg 121:102–107, 1986Google Scholar
  4. 4.
    Alverdy JC, Aoys E, Moss GS: Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 104:195–190, 1988Google Scholar
  5. 5.
    Deitch EA, Berg R, Specian R: Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 122:185–190, 1987Google Scholar
  6. 6.
    Deitch EA, Sittig K, Li M, Berg R, Specian RD: Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159:79–84, 1990Google Scholar
  7. 7.
    Baker JW, Deitch EA, Li M, Berg RD, Specian RD: Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28:896–906, 1988Google Scholar
  8. 8.
    Sori AJ, Rush BF, Lysz TW, Smith W, Machiedo GW: The gut as source of sepsis after hemorrhagic shock. Am J Surg 155:187–192, 1988Google Scholar
  9. 9.
    Runkel NS, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, Miller TA: The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51:18–23, 1991Google Scholar
  10. 10.
    Berg RD: Promotion of the translocation of enteric bacteria from the gastrointestinal tract of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect Immun 33:854–861, 1981Google Scholar
  11. 11.
    Morehouse JL, Specian RD, Stewart JJ, Berg RD: Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology 91:673–682, 1986Google Scholar
  12. 12.
    Redan JA, Rush BF, Lysz TW, Smith S, Machiedo GW: Organ distribution of gut-derived bacteria caused by bowel manipulation ischemia. Am J Surg 159:85–90, 1990.Google Scholar
  13. 13.
    Berg RD: Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents. Curr Microbiol 8:285–292, 1983Google Scholar
  14. 14.
    Owens WE, Berg RD: Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice. Infect Immun 27:461–467, 1982Google Scholar
  15. 15.
    Maddaus MA, Wells CL, Platt JL, Condie RM, Simmons RL: Effect of T cell modulation on the translocation of the bacteria from the gut and mesenteric lymph node. Ann Surg 207:387–398, 1988Google Scholar
  16. 16.
    Scott LD, Cahall DL: Influence of the interdigestive myoelectric complex on enteric flora in the rat. Gastroenterology 82:737–745, 1982Google Scholar
  17. 17.
    Stewart JJ, Weisbrodt NW, Burks TF: Central and peripheral actions of morphine on intestinal transit. J Pharmacol Exp Ther 205:547–555, 1978Google Scholar
  18. 18.
    Runkel NS, Moody FG, Smith GS, Rodriguez LF, Chen Y, Miller TA: Reduced bowel motility by morphine enhances bacterial translocation. Gastroenterology 100:A489, 1991Google Scholar
  19. 19.
    Summers RW, Kent TH, Osborne JW: Effect of drugs, obstruction and irradiation on rat gastrointestinal propulsion. Gastroenterology 59:731–739, 1970Google Scholar
  20. 20.
    Miller MS, Galligan JJ, Burns TF: Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 6:211–217, 1981Google Scholar
  21. 21.
    Lennette EH, Balows A, Hausler WJ, Shadomy HJ (eds). Manual of Clinical Microbiology. Washington D.C., American Society for Microbiology, 1985Google Scholar
  22. 22.
    Dack GM, Petran E: Bacterial activity in different levels of the intestine. J Infect Dis 54:204–220, 1934Google Scholar
  23. 23.
    Dixon JMS: The fate of bacteria in the small intestine. J Pathol Bacteriol 79:131–140, 1960Google Scholar
  24. 24.
    Summers RW, Kent TH: Effects of altered propulsion on rat small intestinal flora. Gastroenterology 59:740–744, 1970Google Scholar
  25. 25.
    Pearson AJ, Brzechwa-Ajdukiewicz A, McCarthy CF: Intestinal pseudoobstruction with bacterial overgrowth in the small intestine. Am J Dig Dis 14:200–205, 1969Google Scholar
  26. 26.
    Van Trappen G, Janssens J, Hellemans J, Ghoos Y: The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59:1158–1166, 1977Google Scholar
  27. 27.
    Dixon JMS, Paulley JW: Bacteriological and histological studies of the small intestine of rats treated with mecamylamine. Gut 4:169–173, 1973Google Scholar
  28. 28.
    Weisbrodt NW, Sussman SE, Stewart JJ, Burks TF: Effects of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of rats. J Pharmacol Exp Ther 214:333–338, 1980Google Scholar
  29. 29.
    Deitch EA, Bridges WM, Ma JW, Ma L, Berg RD: Obstructed intestine as a reservoir for systemic infection. Am J Surg 159:394–401, 1990Google Scholar
  30. 30.
    Berg RD, Owens WE: Inhibition of translocation of viableEscherichia coli from the gastrointestinal tract of mice by bacterial antagonism. Infect Immun 29:1073–1981, 1980Google Scholar
  31. 31.
    Steffen EK, Berg RD: Relationship between cecal population levels of indigenous bacteria and the tranlocation to the mesenteric lymph nodes. Infect Immun 39:1252–1259, 1983Google Scholar
  32. 23.
    Savage DC, Dubos R, Schaedler RW: The gastrointestinal epithelium and its autochronous bacterial flora. J Exp Med 127:67–76, 1968Google Scholar
  33. 33.
    Mediratta PK, Das N, Gupta VS, Sen P: Modulation of humoral immune responses by endogenous opioids. J Allergy Clin Immunol 81:27–32, 1988Google Scholar
  34. 34.
    Hendrickson M, Shelby J, Sullivan JJ, Saffle JR: Naloxone inhibits thein vivo immunosuppressive effects of morphine and thermal injury in mice. J Burn Care Rahab 10:494–498, 1989Google Scholar
  35. 35.
    Wells CL, Maddaus MA, Jechorek RP, Simmons RL: Ability of intestinalEscherichia coli to survive within mesenteric lymph nodes. Infect Immun 55:2834–2837, 1987Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • Norbert S. F. Runkel
    • 1
    • 2
  • Frank G. Moody
    • 1
    • 2
  • Gregory S. Smith
    • 1
    • 2
  • Liliana F. Rodriguez
    • 1
    • 2
  • Ying Chen
    • 1
    • 2
  • Mark T. Larocco
    • 1
    • 2
  • Thomas A. Miller
    • 1
    • 2
  1. 1.Department of SurgeryUniversity of Texas Medical SchoolHouston
  2. 2.Department of Pathology and Laboratory MedicineThe University of Texas Medical SchoolHouston

Personalised recommendations